• Nadeem Ul Haq Combined Military Hospital Quetta/National University of Medical Sciences (NUMS) Pakistan
  • Zeeshan Ayub Sheikh PAF Hospital, Sargodha Pakistan
  • Ahmed Hasan Ashfaq Holy Family Hospital, Islamabad Pakistan
  • Azeema Ahmed PAF Hospital, Sargodha Pakistan
  • Naeema Ahmed Army Medical College/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Keywords: Hyperlipidemias, Rosuvastatin, Sensorineural hearing loss


Objective: To determine the role of Rosuvastatin as a possible treatment of sudden sensorineural hearing loss.

Study Design: Quasi-experimental study.

Place and Duration of Study: ENT Departments, Combined Military Hospital Quetta & Combined Military Hospital Lahore, from Apr 2015 to Sep 2017.

Methodology: This quasi-experimental study performed at Combined Military Hospital Quetta & Combined Military Hospital Lahore comprised of seventy-eight patients of sudden sensorineural hearing loss (SSNHL) having hyperlipidemia. Patients pre-treatment total serum cholesterol was measured, and hearing loss in speech frequencies was recorded on audiometry. The seventy-eight patients were administered tablet Rosuvastatin 10mg once daily with low fat diet for 4 months. On completion of 4 months of treatment, patients were selected by using non probability purposive sampling and divided into responder and non-responder group depending on total serum cholesterol levels. Post treatment total serum cholesterol levels and improvement in hearing levels were also recorded and graded according to siegel’s criteria.

Results: Total serum cholesterol came to within normal limits in 43 (55.1%) patients (responder), while it remained high in 35 (44.9%) patients (non-responder group). Improvement in hearing scores was assessed using siegel’s criteria. pearson chi square test showed statistically significant improvement (p=0.001) in hearing scores among responder group as compared to non-responder group.

Conclusion: Sudden sensorineural hearing loss, in patients having hyperlipidemia, can be managed by treating hyperlipidemia with lipidlowering agent rosuvastatin.


Download data is not yet available.
How to Cite
Haq, N., Sheikh, Z., Ashfaq, A., Ahmed, A., & Ahmed, N. (2019). ROSUVASTATIN AS A POSSIBLE TREATMENT FOR SUDDEN SENSORINEURAL HEARING LOSS. Pakistan Armed Forces Medical Journal, 69(6), 1184-88. Retrieved from
Original Articles

Most read articles by the same author(s)